SMTL ID : 5nhj.1

Human Erk2 with an Erk1/2 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: R.210, R.213, Y.252 4 PLIP interactions: 4 interactions with chain A Water bridges: A:Y.252, A:Y.252 Salt bridges: A:R.210, A:R.213 SO4.2: 3 residues within 4Å: Chain A: G.53, A.54, R.86 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:A.54 Water bridges: A:Y.55, A:R.86 Salt bridges: A:R.86

1 x 8XE: 5-(2-methoxyethyl)-2-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-6,7-dihydro-1~{H}-pyrrolo[3,2-c]pyridin-4-one(Non-covalent)

8XE.3: 18 residues within 4Å: Chain A: I.50, G.53, G.56, M.57, V.58, A.71, K.73, D.125, L.126, M.127, E.128, T.129, D.130, K.133, S.172, L.175, C.185, D.186 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.50, A:V.58, A:A.71, A:L.175, A:L.175 Hydrogen bonds: A:K.73, A:M.127, A:M.127, A:D.186

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, R.A. et al., Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point. J. Med. Chem. (2017)

Release Date

2017-04-19

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence